Drawing for UNIVERSAL CANCER IMMUNOTHERAPY

USPTO serial 99053458

UNIVERSAL CANCER IMMUNOTHERAPY

Reviewed by CopyMark Law Group

Status 760
Filing date
Status date
Registration date
—
Examiner
DELGIZZI, RONALD ERNEST
Law office
TMEG LAW OFFICE 107

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with UNIVERSAL CANCER IMMUNOTHERAPY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ALICIA M. PASSERIN

ALICIA M. PASSERIN LEECH TISHMAN FUSCALDO & LAMPL, LLC525 WILLIAM PENN PLACE, 28TH FLOORPITTSBURGH, PA 15219UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Biological preparations for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Vaccines; Veterinary pharmaceutical preparations for the prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Veterinary pharmaceutical preparations for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 25, 2026GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Oct 25, 2026GNSFSUBSEQUENT FINAL EMAILED—
Oct 25, 2026CFRCSUBSEQUENT FINAL REFUSAL WRITTEN—
Sep 15, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 15, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 15, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 15, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 3, 2026ALIEASSIGNED TO LIE—
Mar 2, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 2, 2026EXPIEX PARTE APPEAL-INSTITUTED—
Mar 2, 2026JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Mar 2, 2026EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jan 28, 2026DOCKASSIGNED TO EXAMINER—
Dec 1, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 1, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 1, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 17, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 14, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 14, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 15, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 15, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 15, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 15, 2025DOCKASSIGNED TO EXAMINER—
Feb 24, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 24, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 24, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance